Egetis Therapeutics AB (publ)
STO:EGTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
D
|
Direct Finance of Direct Group 2006 Ltd
TASE:DIFI
|
IL |
|
Maxvision Technology Corp
SZSE:002990
|
CN |
|
D
|
Daesang Corp
KRX:001680
|
KR |
|
Y
|
Yonyu Plastics Co Ltd
TWSE:1323
|
TW |
|
T
|
Tai United Holdings Ltd
HKEX:718
|
HK |
|
AstroNova Inc
NASDAQ:ALOT
|
US |
|
Mikuni Corp
TSE:7247
|
JP |
|
Clariant AG
OTC:CLZNF
|
CH |
|
H
|
HiteJinro Holdings Co Ltd
KRX:000140
|
KR |
|
Dongwha Pharm Co Ltd
KRX:000020
|
KR |
|
K
|
KSL Holdings Bhd
KLSE:KSL
|
MY |
|
V
|
Vitesse Energy Inc
NYSE:VTS
|
US |
|
Livetiles Ltd
ASX:LVT
|
AU |
|
JFE Systems Inc
TSE:4832
|
JP |
|
S
|
Sella Capital Real Estate Ltd
TASE:SLARL
|
IL |
|
S
|
Shenzhen Xinyichang Technology Co Ltd
SSE:688383
|
CN |
|
P
|
Parnax Lab Ltd
BSE:506128
|
IN |
|
Norsk Hydro ASA
OSE:NHY
|
NO |
|
S
|
Shanghai Shibei Hi-Tech Co Ltd
SSE:600604
|
CN |
|
H
|
Homeland Uranium Corp
XTSX:HLU
|
CA |
|
Cotta Co Ltd
TSE:3359
|
JP |
|
VNV Global AB (publ)
STO:VNV
|
SE |
Wall Street
Price Targets
EGTX Price Targets Summary
Egetis Therapeutics AB (publ)
According to Wall Street analysts, the average 1-year price target for
EGTX
is 13.67 SEK
with a low forecast of 10.1 SEK and a high forecast of 17.85 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EGTX's stock price target?
Price Target
13.67
SEK
According to Wall Street analysts, the average 1-year price target for
EGTX
is 13.67 SEK
with a low forecast of 10.1 SEK and a high forecast of 17.85 SEK.
What is Egetis Therapeutics AB (publ)'s Revenue forecast?
Projected CAGR
180%
The
compound annual growth rate
of Egetis Therapeutics AB (publ)'s revenue for the next 3 years is
180%.
